FLGT.NASDAQFulgent Genetics, INC

Form 4: Fulgent Genetics CFO Sells Shares for Tax Obligations

Sentiment:

Insider Transaction Report

📋All filings for Fulgent Genetics, INC
🔒Login to Follow

Fulgent Genetics CFO Paul Kim disposed of 3,004 shares of common stock to cover tax withholding obligations related to RSU vesting.

Summary

  • Paul Kim, the Chief Financial Officer and Treasurer of Fulgent Genetics, Inc. (FLGT), reported a disposition of common stock.
  • On January 26, 2026, Mr. Kim disposed of 3,004 shares of Fulgent Genetics common stock.
  • The shares were disposed of at a price of $27.53 per share.
  • This transaction was conducted to satisfy tax withholding obligations that arose upon the vesting of certain restricted stock units.
  • These restricted stock units were assumed pursuant to the Agreement and Plan of Merger dated November 7, 2022.
  • Following this transaction, Mr. Kim beneficially owns 328,146 shares of Fulgent Genetics common stock directly.

Sentiment

Score: 5

Explanation: The filing reports a routine insider transaction for tax withholding purposes, which is a neutral event and does not indicate positive or negative sentiment regarding the company's performance or prospects.

Future Outlook

This filing does not contain any forward-looking statements or guidance regarding the company's future performance or outlook.

Industry Context

This filing details a routine insider transaction related to executive compensation and tax obligations, which is common across all industries and does not reflect specific industry trends or competitive dynamics.

Stakeholder Impact

  • Shareholders: Minimal impact as this is a routine, non-discretionary transaction for tax purposes and does not signal a change in management's confidence or company fundamentals.
  • Employees: No direct impact mentioned.

Key Dates

DateDescription
11/07/2022Date of the Agreement and Plan of Merger from which restricted stock units were assumed.
01/26/2026Date of the reported transaction where shares were disposed of for tax withholding.
01/28/2026Date the Form 4 was signed and filed.

Recommendation

hold

This Form 4 filing details a routine, non-discretionary sale of shares by an insider to cover tax obligations upon RSU vesting. It does not provide any new information regarding the company's operational performance, financial health, or strategic direction. Therefore, it does not warrant a change in investment recommendation, and a 'hold' stance is maintained based solely on the information presented in this filing.

Keywords

Fulgent Genetics, FLGT, Form 4, Insider Transaction, Paul Kim, CFO, Stock Sale, RSU, Tax Withholding

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.